0000921582FALSE00009215822024-10-302024-10-300000921582dei:OtherAddressMember2024-10-302024-10-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934

October 30, 2024

Date of report (Date of earliest event reported)

IMAX Corporation
(Exact Name of Registrant as Specified in Its Charter)


Canada001-3506698-0140269
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification Number)

2525 Speakman Drive
902 Broadway, Floor 20
Mississauga, Ontario, Canada L5K 1B1
New York, New York, USA 10010
(905) 403-6457
(212) 821-0142

(Address of principal executive offices, zip code, telephone numbers)
N/A
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Common Shares, no par valueIMAXThe New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter):

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 2.02    Results of Operations and Financial Condition

On October 30, 2024, IMAX Corporation (the “Company”) issued a press release announcing the Company’s financial and operating results for the quarter ended September 30, 2024, a copy of which is attached as Exhibit 99.1.

The information in this current report on Form 8-K, including the Exhibit attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01    Financial Statements and Exhibits

Exhibits

Exhibit
No.
Description
99.1
104Cover Page Interactive Data File (formatted as inline XBRL).

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

IMAX Corporation
(Registrant)
Date: October 30, 2024
By:/s/ Richard L. Gelfond
Name:Richard L. Gelfond
Title:Chief Executive Officer & Director
3

Exhibit 99.1
image_0.jpg

IMAX CORPORATION REPORTS
THIRD QUARTER 2024 EARNINGS RESULTS

•Global entertainment platform delivers Net Income of $14 million (+16% YoY), EPS(1) of 26 cents (+18% YoY), and Cash from Operations of $35 million (+23% YoY)

•Strong profitability highlighted by Total Adjusted EBITDA(2) of $39 million at a 42% margin; and Adjusted EPS(1)(2) of 35 cents, matching a third quarter record

•Network growth accelerates as IMAX expects to deliver on high-end of full-year installation guidance, with 49 system installs (+63% YoY) worldwide in Q3

•Sales activity robust as system signings climb to 119 to-date — outpacing 129 signings for full-year 2023

•Strong, diverse year-end slate including “Gladiator II,” “Wicked,” “Moana 2,” and “Mufasa: The Lion King” poised to drive momentum heading into 2025

•IMAX expects to deliver record of more than $1.2 billion in global box office in 2025 as promising slate solidifies


NEW YORK, NY — October 30, 2024 — IMAX Corporation (NYSE: IMAX) today reported solid financial results for the third quarter of 2024, demonstrating the value of its unique global entertainment platform and broad content portfolio.

“IMAX continues to set the table for a new, sustained era of growth with a 2025 and 2026 slate that is as promising as we’ve ever seen,” said Rich Gelfond, CEO of IMAX. “With an exceptional content pipeline, accelerating system installations, and robust sales activity worldwide, we are very well-positioned to execute and capitalize on the opportunity ahead over the next several years.”
“As we look forward, we expect 2025 to be our best year ever at the global box office, with more than $1.2 billion in IMAX grosses worldwide. Our slate next year is highlighted by at least 14 Filmed for IMAX® releases worldwide shot with our cameras, for our screens — a historical indicator of higher indexing for our platform and further proof that filmmakers and audiences prefer the awe-inspiring IMAX Experience®.”
“Demand for the IMAX platform is strong among our global exhibition partners. We installed nearly 50 new and upgraded systems worldwide in the third quarter — one of our best third quarters for installs ever — and continue to strike agreements in key growth markets, including Australia, France, Japan, and Saudi Arabia.”
“Our third quarter performance further demonstrates our ability to deliver results in any environment, reflecting our flexible, asset-lite business model and diversified content portfolio. With a strong slate ahead, we look forward to fully capitalizing on our model, our strong brand and technology, and our unique global scale to deliver for our shareholders.”

_______________
(1)Diluted Net Income Per Share
(2)Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the non-GAAP financial measures used herein, as well as reconciliations to the most comparable GAAP amounts.

1

Third Quarter Financial Highlights

Three Months Ended
Nine Months Ended
September 30,September 30,
In millions of U.S. Dollars, except per share data20242023YoY %
Change		20242023YoY %
Change
Total Revenue$91.5 $103.9 (12 %)$259.5 $288.8 (10 %)
Gross Margin$51.0 $62.7 (19 %)$141.8 $170.7 (17 %)
Gross Margin (%)55.8 %60.4 %54.6 %59.1 %
Total Adjusted EBITDA(1)(2)
$38.7 $50.5 (23 %)$101.7 $118.8 (14 %)
Total Adjusted EBITDA Margin (%)(1)(2)
42.3 %48.6 %39.2 %41.1 %
Net Income(3)
$13.9 $12.0 16 %$20.8 $22.8 (9 %)
Diluted Net Income Per Share(3)
$0.26 $0.22 18 %$0.39 $0.41 (5 %)
Adjusted Net Income(1)(3)
$18.9 $19.4 (3 %)$36.5 $42.8 (15 %)
Adjusted Earnings Per Share(1)(3)
$0.35 $0.35 — %$0.68 $0.77 (12 %)
Weighted average shares outstanding (in millions):
Basic52.7 54.6 (4 %)52.6 54.4 (3 %)
Diluted54.1 55.5 (3 %)53.6 55.3 (3 %)
image_1.jpg
(1)Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the non-GAAP financial measures used herein, as well as reconciliations to the most comparable GAAP amounts.
(2)Total Adjusted EBITDA is before adjustments for non-controlling interests. Total Adjusted EBITDA per Credit Facility attributable to common shareholders, excluding non-controlling interests, was $35.6 million and $90.5 million for each of the three and nine months ended September 30, 2024 (2023 - $45.1 million and $105.1 million). The Company’s Credit Facility covenant is calculated on a trailing twelve month basis.
(3)Attributable to common shareholders.

2

Third Quarter Segment Results(1)
Content SolutionsTechnology Products and Services
  Revenue    
 Gross Margin
Gross
  Margin %
  Revenue    
 Gross Margin
Gross
  Margin %
3Q24$30.1 $16.4 55 %$58.0 $32.0 55 %
3Q2344.2 26.4 60 %56.2 33.8 60 %
% change
(32 %)(38 %)3 %(5 %)
YTD24$99.2 $54.7 55 %$152.0 $81.3 54 %
YTD23107.6 64.4 60 %171.8 100.1 58 %
% change
(8 %)(15 %)(12 %)(19 %)
image_1.jpg
(1)Please refer to the Company’s Form 10-Q for the period ended September 30, 2024 for additional segment information.

Content Solutions Segment

•Content Solutions revenues of $30 million decreased 32% year-over-year driven by the mix of content, which included “Oppenheimer” — the Company’s fifth highest grossing title of all time — in the year prior. Despite the decline, the third quarter 2024 was the third highest grossing third quarter in IMAX history

•Gross margin for Content Solutions of $16 million decreased 38% compared to the third quarter of the prior year period.

Technology Products and Services Segment

•Technology Products and Services revenues and gross margin increased 3% year-over-year to $58 million and decreased 5% year-over-year to $32 million, respectively, driven by system installation growth that is outpacing the prior year and offset the lower box office related rental revenue.

•During the third quarter the Company installed 49 systems compared to 30 systems in the third quarter of 2023, an increase of 63% year-over-year. Of those, 20 systems were under sales arrangements, compared to 16 systems in the prior year.

•Commercial network growth continues with the number of IMAX locations increasing 4% year-over-year to 1,714 systems. The Company ended Q3 2024 with a backlog of 472 IMAX systems.

Operating Cash Flow and Liquidity

Net cash provided by operating activities for year to date September 2024 was $59 million compared to $55 million in the prior year period. Third quarter 2024 net cash provided by operating activities was $35 million compared to $29 million in the prior year period with the increase reflecting improvements in working capital.

As of September 30, 2024, the Company’s available liquidity was $413 million. The Company’s liquidity includes cash and cash equivalents of $105 million, $253 million in available borrowing capacity under the Credit Facility, and $56 million in available borrowing capacity under IMAX China’s revolving facilities. Total debt, excluding deferred financing costs, was $280 million as of September 30, 2024.

In 2021, the Company issued $230.0 million of 0.500% Convertible Senior Notes due 2026 (“Convertible Notes”). In connection with the pricing of the Convertible Notes, the Company entered into privately negotiated capped call transactions with an initial cap price of $37.2750 per share of the Company’s common shares.

Share Count and Capital Return

The weighted average basic and diluted shares outstanding in the third quarter of 2024 were 52.7 million and 54.1 million, respectively, compared to 54.6 million and 55.5 million in the third quarter of 2023, a decrease of 3.5% and 2.6%, respectively.

For the nine months ended September 30, 2024, the Company repurchased 1,166,370 common shares at an average price of $13.99 for a total of $16 million, excluding commissions.

3

The Company is authorized under its share-repurchase program, expiring June 30, 2026 to repurchase up to $400 million of its common shares, of which approximately $151 million remains available.

Supplemental Materials

For more information about the Company’s results, please refer to the IMAX Investor Relations website located at investors.imax.com.

Investor Relations Website and Social Media

On a monthly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at investors.imax.com. The Company expects to provide such updates within five business days of month-end, although the Company may change this timing without notice.

The Company may post additional information on the Company’s corporate and Investor Relations website which may be material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company’s website in addition to the Company’s press releases, SEC filings and public conference calls and webcasts, for additional information about the Company.

Conference Call

The Company will host a conference call today at 4:30 PM ET to discuss its third quarter 2024 financial results. This call is being webcast and can be accessed at investors.imax.com. To access the call via telephone, interested parties please pre-register here: https://register.vevent.com/register/BId903a31ed4674fefba1f8b3fdf34072c and you will be provided with a dial-in number and unique pin. To avoid delays, we encourage participants to dial into the conference call ten minutes ahead of the scheduled start time. A replay of the call will be available via webcast at investors.imax.com.

4

About IMAX Corporation

IMAX, an innovator in entertainment technology, combines proprietary software, architecture, and equipment to create experiences that take you beyond the edge of your seat to a world you’ve never imagined. Top filmmakers and studios are utilizing IMAX systems to connect with audiences in extraordinary ways, making IMAX’s network among the most important and successful theatrical distribution platforms for major event films around the globe.

IMAX is headquartered in New York, Toronto, and Los Angeles, with additional offices in London, Dublin, Tokyo, and Shanghai. As of September 30, 2024, there were 1,788 IMAX systems (1,714 commercial multiplexes, 12 commercial destinations, 62 institutional) operating in 89 countries and territories. Shares of IMAX China Holding, Inc., a subsidiary of IMAX Corporation, trade on the Hong Kong Stock Exchange under the stock code “1970”.

IMAX®, IMAX® 3D, Experience It In IMAX®, The IMAX Experience®, DMR®, Filmed For IMAX®, IMAX LIVETM, IMAX Enhanced®, IMAX StreamSmartTM, and SSIMWAVE® are trademarks and trade names of IMAX Corporation or its subsidiaries that are registered or otherwise protected under laws of various jurisdictions. For more information, visit www.imax.com. You can also connect with IMAX on Instagram (www.instagram.com/company/imax), Facebook (www.facebook.com/imax), LinkedIn (www.linkedin.com/company/imax), X (www.twitter.com/imax), and YouTube (www.youtube.com/imaxmovies).

For additional information please contact:

Investors:
IMAX Corporation, New York
Jennifer Horsley
212-821-0154
jhorsley@IMAX.com
Media:
IMAX Corporation, New York
Mark Jafar
212-821-0102
mjafar@imax.com




5

Forward-Looking Statements

This earnings release contains forward looking statements that are based on IMAX management’s assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. These forward-looking statements include, but are not limited to, references to business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, future capital expenditures (including the amount and nature thereof), industry prospects and consumer behavior, plans and references to the future success of IMAX Corporation together with its consolidated subsidiaries (the “Company”) and expectations regarding the Company’s future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada, as well as geopolitical conflicts; risks related to the Company’s growth and operations in China; the performance of IMAX remastered films and other films released to the IMAX network; the signing of IMAX System agreements; conditions, changes and developments in the commercial exhibition industry; risks related to currency fluctuations; the potential impact of increased competition in the markets within which the Company operates, including competitive actions by other companies; the failure to respond to change and advancements in technology; risks relating to consolidation among commercial exhibitors and studios; risks related to brand extensions and new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to cyber-security and data privacy; risks related to the Company’s inability to protect the Company’s intellectual property; risks associated with the Company’s use of artificial intelligence and exploration of additional use cases of artificial intelligence; risks related to climate change; risks related to weather conditions and natural disasters that may disrupt or harm the Company’s business; risks related to the Company’s indebtedness and compliance with its debt agreements; general economic, market or business conditions; risks related to political, economic and social instability; the failure to convert system backlog into revenue; changes in laws or regulations; any statements of belief and any statements of assumptions underlying any of the foregoing; other factors and risks outlined in the Company’s periodic filings with the SEC; and other factors, many of which are beyond the control of the Company. Consequently, all of the forward-looking statements made in this earnings release are qualified by these cautionary statements, and actual results or anticipated developments by the Company may not be realized, and even if substantially realized, may not have the expected consequences to, or effects on, the Company. These factors, other risks and uncertainties and financial details are discussed in the Company’s most recent Annual Report on Form 10-K. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events or otherwise.




6

Primary Reporting Groups

The Company’s Chief Executive Officer (“CEO”) is its CODM, as such term is defined under U.S. GAAP. The CODM assesses segment performance based on segment revenues and segment gross margins. Selling, general and administrative expenses, research and development costs, the amortization of intangible assets, provision for (reversal of) current expected credit losses, certain write-downs, interest income, interest expense, and income tax (expense) benefit are not allocated to the Company’s segments.

In the first quarter of 2023, the Company revised its internal segment reporting, including the information provided to the CODM to assess segment performance and allocate resources. Accordingly, the Company has two reportable segments:

(i)Content Solutions, which principally includes the digital remastering of films and other content into IMAX formats for distribution to the IMAX network. To a lesser extent, the Content Solutions segment also earns revenue from the distribution of large-format documentary films and exclusive experiences ranging from live performances to interactive events with leading artists and creators, as well as film post-production services.

(ii)Technology Products and Services, which includes results from the sale or lease of IMAX Systems, as well as from the maintenance of IMAX Systems. To a lesser extent, the Technology Product and Services segment also earns revenue from certain ancillary theater business activities, including after-market sales of IMAX System parts and 3D glasses.

Transactions between segments are valued at exchange value. Inter-segment profits are eliminated upon consolidation, as well as for the disclosures below.

7

IMAX Network and Backlog

Three Months Ended
Nine Months Ended
September 30,September 30,
2024202320242023
System Signings(1):
Sales Arrangements10 13 40 54 
Traditional JRSA6 7 71 40 
Total IMAX System Signings16 20 111 94 

(1) System signings include new signings of 15 in Q3 2024, 14 in Q3 2023, 42 in the first three quarters of 2024 and 76 in the first three quarters of 2023.

Three Months Ended
Nine Months Ended
September 30,September 30,
2024202320242023
System Installations(1):
Sales Arrangements20 16 35 35 
Hybrid JRSA— — 1 2 
Traditional JRSA29 14 52 22 
Total IMAX System Installations49 30 88 59 

(1) System installations include new systems installations of 17 in Q3 2024, 18 in Q3 2023, 45 in the first three quarters of 2024 and 39 in the first three quarters of 2023.
As of September 30,
20242023
System Backlog:
Sales Arrangements170 192 
Hybrid JRSA95 107 
Traditional JRSA207 187 
Total System Backlog472 486 
As of September 30,
20242023
System Network:
Commercial Multiplex Systems
Sales Arrangements820 743 
Hybrid JRSA129 137 
Traditional JRSA765 771 
Total Commercial Multiplex Systems1,714 1,651 
Commercial Destination Systems12 12 
Institutional Systems62 68 
Total System Network1,788 1,731 

8

IMAX CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands of U.S. dollars, except per share amounts)
(Unaudited)

Three Months Ended
Nine Months Ended
September 30,
September 30,
2024202320242023
Revenues
Technology sales
$26,305 $18,273 $54,629 $65,455 
Image enhancement and maintenance services
46,891 60,250 149,428 154,244 
Technology rentals
16,122 23,008 48,766 62,612 
Finance income
2,134 2,365 6,713 6,510 
91,452 103,896 259,536 288,821 
Costs and expenses applicable to revenues
Technology sales
10,605 7,948 24,594 28,951 
Image enhancement and maintenance services
23,087 26,646 73,371 69,470 
Technology rentals
6,741 6,587 19,736 19,747 
40,433 41,181 117,701 118,168 
Gross margin
51,019 62,715 141,835 170,653 
Selling, general and administrative expenses
31,466 36,282 100,287 109,336 
Research and development
(265)2,771 3,953 7,388 
Amortization of intangible assets
1,544 1,107 4,208 3,328 
Credit loss (reversal) expense, net
(1,137)523 (963)1,589 
Restructuring and executive transition costs
— — — 1,353 
Income from operations
19,411 22,032 34,350 47,659 
Realized and unrealized investment gains
32 364 94 436 
Retirement benefits non-service expense
(109)(77)(323)(232)
Interest income
625 738 1,720 1,838 
Interest expense
(2,240)(1,483)(6,467)(5,045)
Income before taxes
17,719 21,574 29,374 44,656 
Income tax expense
(2,376)(6,555)(3,538)(14,901)
Net income
15,343 15,019 25,836 29,755 
Net income attributable to non-controlling interests
(1,447)(3,029)(5,083)(6,960)
Net income attributable to common shareholders
$13,896 $11,990 $20,753 $22,795 
Net income per share attributable to common shareholders:
Basic
$0.26 $0.22 $0.39 $0.42 
Diluted
$0.26 $0.22 $0.39 $0.41 
Weighted average shares outstanding (in thousands):
Basic52,682 54,618 52,605 54,424 
Diluted54,089 55,535 53,628 55,261 
Additional Disclosure:
Depreciation and amortization$14,900 $19,279 $48,902 $46,477 
Amortization of deferred financing costs$493 $492 $1,478 $1,742 
9

IMAX CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands of dollars, except share amounts)
(Unaudited)

September 30,December 31,
20242023
Assets
Cash and cash equivalents$104,504 $76,200 
Accounts receivable, net of allowance for credit losses114,193 136,259 
Financing receivables, net of allowance for credit losses123,459 127,154 
Variable consideration receivables, net of allowance for credit losses74,487 64,338 
Inventories37,612 31,584 
Prepaid expenses13,310 12,345 
Film assets, net of accumulated amortization9,127 6,786 
Property, plant and equipment, net of accumulated depreciation245,106 243,299 
Other assets22,981 20,879 
Deferred income tax assets, net of valuation allowance15,687 7,988 
Goodwill52,815 52,815 
Other intangible assets, net of accumulated amortization34,279 35,022 
Total assets$847,560 $814,669 
Liabilities
Accounts payable$26,018 $26,386 
Accrued and other liabilities111,283 111,013 
Deferred revenue53,676 67,105 
Revolving credit facility borrowings, net of unamortized debt issuance costs46,239 22,924 
Convertible notes and other borrowings, net of unamortized discounts and debt issuance costs230,038 229,131 
Deferred income tax liabilities12,521 12,521 
Total liabilities479,775 469,080 
Commitments, contingencies and guarantees
Non-controlling interests674 658 
Shareholders’ equity
Capital stock common shares — no par value. Authorized — unlimited number.
52,682,641 issued and outstanding (December 31, 2023 — 53,260,276 issued and outstanding)
394,603 389,048 
Other equity181,911 185,087 
Statutory surplus reserve3,932 3,932 
Accumulated deficit
(279,993)(292,845)
Accumulated other comprehensive loss
(11,015)(12,081)
Total shareholders’ equity attributable to common shareholders
289,438 273,141 
Non-controlling interests77,673 71,790 
Total shareholders’ equity
367,111 344,931 
Total liabilities and shareholders’ equity
$847,560 $814,669 





10

IMAX CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands of dollars)
(Unaudited)


Nine Months Ended
September 30,
20242023
Operating Activities
Net income
$25,836 $29,755 
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization
48,902 46,477 
Amortization of deferred financing costs
1,478 1,742 
Credit loss (reversal) expense, net
(963)1,589 
Write-downs, including asset impairments
3,034 872 
Deferred income tax benefit
(7,339)(3,724)
Share-based and other non-cash compensation
17,261 17,830 
Unrealized foreign currency exchange (gain) loss
(527)52 
Realized and unrealized investment gain
(94)(436)
Changes in assets and liabilities:
Accounts receivable
23,001 (2,392)
Inventories(6,181)(13,771)
Film assets
(17,892)(14,575)
Deferred revenue
(13,393)(4,670)
Changes in other operating assets and liabilities
(13,771)(4,141)
Net cash provided by operating activities
59,352 54,608 
Investing Activities
Purchase of property, plant and equipment
(3,816)(2,541)
Investment in equipment for joint revenue sharing arrangements
(21,728)(10,705)
Acquisition of other intangible assets
(4,802)(5,418)
Net cash used in investing activities
(30,346)(18,664)
Financing Activities
Revolving credit facility borrowings55,000 31,032 
Repayments of revolving credit facility borrowings(32,000)(43,057)
Repayments of other borrowings
(489)— 
Proceeds from other borrowings
— 315 
Repurchase of common shares(18,102)(4,263)
Taxes withheld and paid on employee stock awards vested(4,978)(6,458)
Common shares issued - stock options exercised
98 — 
Principal payment under finance lease obligations
(480)(480)
Dividends paid to non-controlling interests
— (1,438)
Net cash used in financing activities
(951)(24,349)
Effects of exchange rate changes on cash
249 607 
Increase in cash and cash equivalents during period
28,304 12,202 
Cash and cash equivalents, beginning of period
76,200 97,401 
Cash and cash equivalents, end of period
$104,504 $109,603 

11

Segment Revenue and Gross Margin

Three Months Ended
Nine Months Ended
September 30,September 30,
(In thousands of dollars)2024202320242023
Revenue
Content Solutions$30,129 $44,214 $99,218 $107,605 
Technology Products and Services57,971 56,169 152,019 171,813 
Sub-total for reportable segments88,100 100,383 251,237 279,418 
All Other(1)
3,352 3,513 8,299 9,403 
Total$91,452 $103,896 $259,536 $288,821 
Gross Margin
Content Solutions$16,449 $26,407 $54,686 $64,397 
Technology Products and Services31,964 33,761 81,331 100,066 
Sub-total for reportable segments48,413 60,168 136,017 164,463 
All Other(1)
2,606 2,547 5,818 6,190 
Total$51,019 $62,715 $141,835 $170,653 
image_1.jpg
(1)All Other includes the results from the Company’s streaming and consumer technology business, as well as other ancillary activities.











12

IMAX CORPORATION
NON-GAAP FINANCIAL MEASURES
(In thousands of U.S. dollars)

In this release, the Company presents adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per basic and diluted share, EBITDA, Adjusted EBITDA per Credit Facility, Adjusted EBITDA margin as supplemental measures of the Company’s performance, which are not recognized under U.S. GAAP. Adjusted net income or loss attributable to common shareholders and adjusted net income or loss attributable to common shareholders per basic and diluted share exclude, where applicable: (i) share-based compensation; (ii) realized and unrealized investment gains or losses; (iii) transaction-related expenses; and (iv) restructuring and executive transition costs, as well as the related tax impact of these adjustments.

The Company believes that these non-GAAP financial measures are important supplemental measures that allow management and users of the Company’s financial statements to view operating trends and analyze controllable operating performance on a comparable basis between periods without the after-tax impact of share-based compensation and certain unusual items included in net income attributable to common shareholders. Although share-based compensation is an important aspect of the Company’s employee and executive compensation packages, it is a non-cash expense and is excluded from certain internal business performance measures.

A reconciliation from net income (loss) attributable to common shareholders and the associated per share amounts to adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below. Net income (loss) attributable to common shareholders and the associated per share amounts are the most directly comparable GAAP measures because they reflect the earnings relevant to the Company’s shareholders, rather than the earnings attributable to non-controlling interests.

In addition to the non-GAAP financial measures discussed above, management also uses “EBITDA,” as such term is defined in the Credit Agreement, and which is referred to herein as “Adjusted EBITDA per Credit Facility.” As allowed by the Credit Agreement, Adjusted EBITDA per Credit Facility includes adjustments in addition to the exclusion of interest, taxes, depreciation and amortization. Accordingly, this non-GAAP financial measure is presented to allow a more comprehensive analysis of the Company’s operating performance and to provide additional information with respect to the Company’s compliance with its Credit Agreement requirements, when applicable. In addition, the Company believes that Adjusted EBITDA per Credit Facility presents relevant and useful information widely used by analysts, investors and other interested parties in the Company’s industry to evaluate, assess and benchmark the Company’s results.

EBITDA is defined as net income or loss excluding: (i) income tax expense or benefit; (ii) interest expense, net of interest income; (iii) depreciation and amortization, including film asset amortization; and (iv) amortization of deferred financing costs. Adjusted EBITDA per Credit Facility is defined as EBITDA excluding: (i) share-based and other non-cash compensation; (ii) realized and unrealized investment gains or losses; (iii) transaction-related expenses; (iv) restructuring and executive transition costs; and (v) write- downs, net of recoveries, including asset impairments and credit loss expense.

A reconciliation of net income (loss) attributable to common shareholders, which is the most directly comparable GAAP measure, to EBITDA and Adjusted EBITDA per Credit Facility is presented in the table below. Net income (loss) attributable to common shareholders is the most directly comparable GAAP measure because it reflects the earnings relevant to the Company’s shareholders, rather than the earnings attributable to non-controlling interests.

In this release, the Company also presents free cash flow, which is not recognized under U.S. GAAP, as a supplemental measure of the Company’s liquidity. The Company definition of free cash flow deducts only normal recurring capital expenditures, including the Company’s investment in joint revenue sharing arrangements, the purchase of property, plant and equipment and the acquisition of other intangible assets (from the Consolidated Statements of Cash Flows), from net cash provided by or used in operating activities. Management believes that free cash flow is a supplemental measure of the cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented below.

These non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Additionally, the non-GAAP financial measures used by the Company should not be considered as a substitute for, or superior to, the comparable GAAP amounts.

13

Adjusted EBITDA per Credit Facility

Three Months Ended

(In thousands of U.S. Dollars)
September 30, 2024
September 30, 2023
Revenues$91,452 $103,896 
Reported net income
$15,343 $15,019 
Add (subtract):
Income tax expense
2,376 6,555 
Interest expense, net of interest income
1,123 253 
Depreciation and amortization, including film asset amortization
14,900 19,279 
Amortization of deferred financing costs(1)
493 492 
EBITDA$34,235 $41,598 
Share-based and other non-cash compensation
5,508 5,297 
Unrealized investment gains
(32)(364)
Transaction-related expenses
— 3,086 
Write-downs, including asset impairments and credit loss expense
(1,025)921 
Total Adjusted EBITDA
$38,686 $50,538 
Total Adjusted EBITDA margin
42.3 %48.6 %
Less: Non-controlling interest(3,116)(5,455)
Adjusted EBITDA per Credit Facility - attributable to common shareholders$35,570 $45,083 
image_1.jpg
(1)The amortization of deferred financing costs is recorded within Interest Expense in the Condensed Consolidated Statement of Operations.


Twelve Months Ended

(In thousands of U.S. Dollars)
September 30, 2024(1)
September 30, 2023(1)
Revenues$345,554 $386,867 
Reported net income
$29,147 $33,836 
Add (subtract):
Income tax expense
1,688 16,917 
Interest expense, net of interest income
3,907 2,024 
Depreciation and amortization, including film asset amortization
62,447 60,475 
Amortization of deferred financing costs(2)
1,970 2,454 
EBITDA$99,159 $115,706 
Share-based and other non-cash compensation
23,661 25,893 
Unrealized investment gains
(123)(407)
Transaction-related expenses
327 3,408 
Restructuring and executive transition costs
1,593 1,353 
Write-downs, including asset impairments and credit loss expense
2,359 4,328 
Total Adjusted EBITDA
$126,976 $150,281 
Total Adjusted EBITDA margin
36.7 %38.8 %
Less: Non-controlling interest$(13,422)$(17,363)
Adjusted EBITDA per Credit Facility - attributable to common shareholders$113,554 $132,918 
image_1.jpg
(1)The Senior Secured Net Leverage Ratio is calculated using Adjusted EBITDA per Credit Facility determined on a trailing twelve-month basis.
(2)The amortization of deferred financing costs is recorded within Interest Expense in the Condensed Consolidated Statement of Operations.



14

Adjusted Net Income Attributable to Common Shareholders and Adjusted Net Income Per Share

Three Months Ended
September 30, 2024
Three Months Ended
September 30, 2023
(In thousands of U.S. Dollars, except per share amounts)
Net Income
Per Diluted
Share
Net Income
Per Diluted
Share
Net income attributable to common shareholders
$13,896 $0.26 $11,990 $0.22 
Adjustments(1):
Share-based compensation
5,332 0.10 5,063 0.09 
Unrealized investment gains
(32)— (454)(0.01)
Transaction-related expenses
— — 3,086 0.06 
Tax impact on items listed above
(341)(0.01)(275)— 
Adjusted net income(1)
$18,855 $0.35 $19,410 $0.35 
Weighted average shares outstanding — basic
52,682 54,618 
Weighted average shares outstanding — diluted
54,089 55,535 
image_1.jpg
(1)Reflects amounts attributable to common shareholders.
Nine Months Ended September 30,
20242023
(In thousands of U.S. Dollars, except per share amounts)
Net Income
Per Share
Net Income
Per Share
Net income attributable to common shareholders
$20,753 $0.39 $22,795 $0.41 
Adjustments(1):
Share-based compensation
16,686 0.30 17,110 0.31 
Unrealized investment gains
(94)— (526)(0.01)
Transaction-related expenses
— — 3,242 0.06 
Restructuring and executive transition costs
— — 1,353 0.02 
Tax impact on items listed above
(803)(0.01)(1,184)(0.02)
Adjusted net income(1)
$36,542 $0.68 $42,790 $0.77 
Weighted average shares outstanding — basic
52,605 54,424 
Weighted average shares outstanding — diluted
53,628 55,261 
image_1.jpg
(1)Reflects amounts attributable to common shareholders.


Free Cash Flow
Nine Months Ended
September 30,
(In thousands of U.S. Dollars)20242023
Net cash provided by operating activities
$59,352 $54,608 
Purchase of property, plant and equipment(3,816)(2,541)
Acquisition of other intangible assets(4,802)(5,418)
Free cash flow before growth CAPEX(1)
50,734 46,649 
Investment in equipment for joint revenue sharing arrangements(21,728)(10,705)
Free cash flow$29,006 $35,944 
image_1.jpg
(1)Growth CAPEX is defined as capital expenditures associated with investments in equipment for joint revenue sharing arrangements.

15
v3.24.3
Cover
Oct. 30, 2024
Document Information [Line Items]  
Document Type 8-K
Document Period End Date Oct. 30, 2024
Registrant Name IMAX Corporation
Entity Incorporation, State or Country Code Z4
Entity File Number 001-35066
Entity Tax Identification Number 98-0140269
Entity Address, Address Line One 2525 Speakman Drive
Entity Address, City or Town Mississauga
Entity Address, State or Province ON
Entity Address, Country CA
Entity Address, Postal Zip Code L5K 1B1
City Area Code 905
Local Phone Number 403-6457
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Shares, no par value
Trading Symbol IMAX
Security Exchange Name NYSE
Entity Emerging Growth Company false
Central Index Key 0000921582
Amendment Flag false
Other Address  
Document Information [Line Items]  
Entity Address, Address Line One 902 Broadway
Entity Address, Address Line Two Floor 20
Entity Address, City or Town New York
Entity Address, State or Province NY
Entity Address, Country US
Entity Address, Postal Zip Code 10010
City Area Code 212
Local Phone Number 821-0142
IMAX (NYSE:IMAX)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more IMAX Charts.
IMAX (NYSE:IMAX)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more IMAX Charts.